These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3325220)

  • 1. Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients.
    Bak JF; Nielsen OH; Pedersen O; Beck-Nielsen H
    Diabetes Res; 1987 Nov; 6(3):155-8. PubMed ID: 3325220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic control and acceptance of a regimen of multiple injections using an insulin (novopen) injector in a group of juvenile diabetics].
    Ugart Líbano R; Ruiz de Larrea Pérez C; Edroso Albaina L
    An Esp Pediatr; 1990 Apr; 32(4):299-302. PubMed ID: 2368991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pump versus pen treatment on glycaemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM).
    Schmitz A; Christiansen JS; Christensen CK; Hermansen K; Mogensen CE
    Dan Med Bull; 1989 Apr; 36(2):176-8. PubMed ID: 2651031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pump treatment: effect on glucose homeostasis, metabolites, hormones, insulin antibodies and quality of life.
    Beck-Nielsen H; Richelsen B; Schwartz Sørensen N; Hother Nielsen O
    Diabetes Res; 1985 Jan; 2(1):37-43. PubMed ID: 3888495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of intensified insulin therapy.
    Brunetti P; Bueti A; Antonella MA; Calabrese G; Fabietti PG; Santeusanio F; Massi Benedetti M
    Exp Clin Endocrinol; 1984 Apr; 83(2):130-5. PubMed ID: 6373314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
    Roos AN; Meinders AE
    Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of unstable diabetes mellitus in children and adolescents using insulin administered by a semi-automated syringe, NovoPen].
    Necić S; Nikezić M; Sajić S; Radmanović S
    Srp Arh Celok Lek; 1989; 117(7-8):453-8. PubMed ID: 2688138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different insulin administrations on plasma amino acid profile in insulin-dependent diabetic patients.
    Trevisan R; Marescotti C; Avogaro A; Tessari P; del Prato S; Tiengo A
    Diabetes Res; 1989 Oct; 12(2):57-62. PubMed ID: 2699443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of physical activity on metabolic state within a 3-h interruption of continuous subcutaneous insulin infusion in patients with type 1 diabetes.
    Jankovec Z; Krcma M; Gruberova J; Komorousova J; Tomesova J; Zourek M; Rusavy Z
    Diabetes Technol Ther; 2011 Dec; 13(12):1234-9. PubMed ID: 21877927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basal bolus therapy in adolescent diabetic patients].
    Steinemann MA; Zuppinger K
    Ther Umsch; 1990 Jan; 47(1):22-9. PubMed ID: 2408179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen.
    Saurbrey N; Arnold-Larsen S; Møller-Jensen B; Kühl C
    Diabet Med; 1988 Mar; 5(2):150-3. PubMed ID: 2964981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Catheter-pens"--an alternative to insulin pump treatment?
    Menzel R; Chlup R; Jutzi E; Hildmann W
    Exp Clin Endocrinol; 1990 Feb; 95(1):157-69. PubMed ID: 2335181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.